Search Results 151-160 of 18122 for peptide therapy

1. Publications - Maliha Zahid, M.B.B.S., Ph.D. - Mayo Clinic

   Cell Penetrating Peptides, Novel Vectors for Gene Therapy. Pharmaceutics. 2020 Mar 03; 12(3). View PubMed; Zahid M, Feldman KS, Garcia-Borrero G, Feinstein ...

2. Study Evaluating The Safety And Efficacy Of Semaglutide, And The Fixed-Dose Combination Of Cilofexor And Firsocostat, Alone And In Combination, In Participants With Compensated Cirrhosis (F4) Due To Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

   - History of type 1 diabetes. - Treatment with a glucagon-like peptide-1 receptor agonist (GLP-1 RA) in the period from 90 days prior to the screening visit ...

3. Enhancing the Natriuretic Peptide System in HFpEF - Mayo Clinic

   Enhancing the Natriuretic Peptide System in HFpEF ... therapy; and * CKD defined as glomerular ... peptide levels are low in obese subjects). Group 2 ...

4. The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass - Mayo Clinic

   By condition, treatment or drug name. Search tips. The Contribution of ... The hypothesis of this study is that increased glucagon-like peptide-1 (GLP ...

5. Clinical trials - Oncology (Medical)

   ... therapeutic susceptibility or response to therapy. ... Personalized Neoantigen Peptide ... peptide administered in combination with pembrolizumab to patients with ...

6. Tesamorelin (subcutaneous route) - Side effects & dosage - Mayo Clinic

   These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways ...

7. Mayo Clinic Q&A: New therapies for advanced shoulder issues

   Oftentimes, surgery can be avoided, with many people responding well to nonoperative treatments, such as physical therapy or injections, to decrease their pain ...

8. Pancreatitis Clinical Trials - Mayo Clinic Research

   Efforts will be directed toward understanding the unmet need and therapeutic burden to identify the most critical factors that influence treatment choices/ ...

9. Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE (COMPOSE) - Mayo Clinic

   The purpose of the study is to evaluate the effectiveness, safety and patient-reported outcomes of peptide receptor radionuclide therapy (PRRT) with 177Lu- ...

10. Transplant Medicine Clinical Trials - Medical Professionals

    Jacksonville, Fla. The purpose of this study is to investigate ghrelin, a peptide that mechanistically carries the promise of therapeutics benefit for diverse ...